FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab

BACKGROUND: Immunotherapy has demonstrated remarkable success in treating different cancers. Nonetheless, a large number of patients do not respond, many respond without immediate changes detectable with conventional imaging, and many have unusual immune-related adverse events that cannot be predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Scarpelli, Matthew, Zahm, Christopher, Perlman, Scott, McNeel, Douglas G., Jeraj, Robert, Liu, Glenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354338/
https://www.ncbi.nlm.nih.gov/pubmed/30700328
http://dx.doi.org/10.1186/s40425-019-0516-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354338/
https://www.ncbi.nlm.nih.gov/pubmed/30700328
http://dx.doi.org/10.1186/s40425-019-0516-1

Ejemplares similares